PROJECT
PARTNER

Almirall

Almirall is a global biopharmaceutical company focused on skin health. We collaborate with scientists and healthcare professionals to address patient’s needs through science to improve their lives. Our Noble Purpose is at the core of our work: “Transform the patients’ world by helping them realize their hopes and dreams for a healthy life”. We invest in differentiated and ground-breaking medical dermatology products to bring our innovative solutions to patients in need.
The company, founded in 1943 and headquartered in Barcelona, is publicly traded on the Spanish Stock Exchange and is a member of the IBEX35 (ticker: ALM). Throughout its 78-year history, Almirall has retained a strong focus on the needs of patients. Currently, Almirall has a direct presence in 21 countries and strategic agreements in over 70, through 13 subsidiaries, with about 1,800 employees. Total revenues in 2020 were 814.5 million euros.

Role in the Facilitate Project

Almirall main contribution will be on WP2 with its experience on privacy matters and pharmaceutical law, on WP3 with its expertise for the development of guidance, standards and recommendations for returning of clinical trials data to patients, and on WP4 and WP5 for clinical trials use case specification and stakeholders requirements and end user UI and end-user tools development, respectively